Literature DB >> 14505058

Tight junctions and human diseases.

Norimasa Sawada1, Masaki Murata, Keisuke Kikuchi, Makoto Osanai, Hirotoshi Tobioka, Takashi Kojima, Hideki Chiba.   

Abstract

Tight junctions are intercellular junctions adjacent to the apical end of the lateral membrane surface. They have two functions, the barrier (or gate) function and the fence function. The barrier function of tight junctions regulates the passage of ions, water, and various macromolecules, even of cancer cells, through paracellular spaces. The barrier function is thus relevant to edema, jaundice, diarrhea, and blood-borne metastasis. On the other hand, the fence function maintains cell polarity. In other words, tight junctions work as a fence to prevent intermixing of molecules in the apical membrane with those in the lateral membrane. This function is deeply involved in cancer cell biology, in terms of loss of cell polarity. Of the proteins comprising tight junctions, integral membrane proteins occludin, claudins, and JAMs have been recently discovered. Of these molecules, claudins are exclusively responsible for the formation of tight-junction strands and are connected with the actin cytoskeleton mediated by ZO-1. Thus, both functions of tight junctions are dependent on the integrity of the actin cytoskeleton as well as ATP. Mutations in the claudin14 and the claudin16 genes result in hereditary deafness and hereditary hypomagnesemia, respectively. Some pathogenic bacteria and viruses target and affect the tight-junction function, leading to diseases. In this review, the relationship between tight junctions and human diseases is summarized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505058     DOI: 10.1007/s00795-003-0219-y

Source DB:  PubMed          Journal:  Med Electron Microsc        ISSN: 0918-4287


  114 in total

1.  Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers.

Authors:  Heta Merikallio; Paavo Pääkkö; Terttu Harju; Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2011-09-27

Review 2.  Tight junctions in lung cancer and lung metastasis: a review.

Authors:  Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

Review 3.  Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.

Authors:  Daisuke Kyuno; Hiroshi Yamaguchi; Tatsuya Ito; Tsuyoshi Kono; Yasutoshi Kimura; Masafumi Imamura; Takumi Konno; Koichi Hirata; Norimasa Sawada; Takashi Kojima
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Claudin expression in Barrett's esophagus and adenocarcinoma.

Authors:  Hajnalka Gyõrffy; Agnes Holczbauer; Pál Nagy; Zsuzsa Szabó; Péter Kupcsulik; Csilla Páska; János Papp; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2005-08-30       Impact factor: 4.064

5.  Expression patterns of claudin family of tight-junction proteins in the mouse prostate.

Authors:  Naoyuki Sakai; Hideki Chiba; Hiroki Fujita; Yushi Akashi; Makoto Osanai; Takashi Kojima; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2007-01-27       Impact factor: 4.304

6.  Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9.

Authors:  Nami Nishikiori; Norimasa Sawada; Hiroshi Ohguro
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

7.  IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathway.

Authors:  Naoko Hatakeyama; Takashi Kojima; Kousuke Iba; Masaki Murata; Mia M Thi; David C Spray; Makoto Osanai; Hideki Chiba; Sumio Ishiai; Toshihiko Yamashita; Norimasa Sawada
Journal:  Cell Tissue Res       Date:  2008-10-15       Impact factor: 5.249

8.  Interferon-gamma increased epithelial barrier function via upregulating claudin-7 expression in human submandibular gland duct epithelium.

Authors:  Ayumi Abe; Kenichi Takano; Takashi Kojima; Kazuaki Nomura; Takuya Kakuki; Yakuto Kaneko; Motohisa Yamamoto; Hiroki Takahashi; Tetsuo Himi
Journal:  J Mol Histol       Date:  2016-03-08       Impact factor: 2.611

9.  Different expression of occludin and ZO-1 in primary and metastatic liver tumors.

Authors:  Erika Orbán; Erzsébet Szabó; Gábor Lotz; Péter Kupcsulik; Csilla Páska; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

Review 10.  Claudins in cancer: bench to bedside.

Authors:  Makoto Osanai; Akira Takasawa; Masaki Murata; Norimasa Sawada
Journal:  Pflugers Arch       Date:  2016-09-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.